Chilblains outbreak during COVID-19 pandemic: A Type-I interferonopathy?
作者信息
Mensa-Vilaró Anna, Vicente Asunción, Español-Rego Marta, Antón Jordi, Fabregat Virginia, Fortuny Claudia, González Europa Azucena, Fumadó Victoria, González-Roca Eva, Jou Cristina, Plaza Susana, Mosquera Juan Manuel, Yagüe Jordi, Prat Carolina, Pascal Mariona, Juan Manel, Arostegui Juan I, Baselga Eulalia, Alsina Laia
机构信息
Department of Immunology, Hospital Clínic, Barcelona, Spain.
Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.
出版信息
Pediatr Allergy Immunol. 2022 Oct;33(10):e13860. doi: 10.1111/pai.13860.
Abstract
摘要
相似文献
1
Chilblains outbreak during COVID-19 pandemic: A Type-I interferonopathy?2019冠状病毒病大流行期间冻疮的爆发：一种Ⅰ型干扰素病？
Pediatr Allergy Immunol. 2022 Oct;33(10):e13860. doi: 10.1111/pai.13860.
2
Detection of a second outbreak of chilblain-like lesions during COVID-19 pandemic through teledermatology.通过远程皮肤病学在新冠疫情期间检测到冻疮样病变的第二次暴发。
J Eur Acad Dermatol Venereol. 2021 Sep;35(9):e556-e558. doi: 10.1111/jdv.17378. Epub 2021 Jun 4.
3
Recent outbreak of chilblain-like lesions is not directly related to SARS-CoV-2 infection.近期冻疮样病变的爆发与新型冠状病毒感染没有直接关系。
J Eur Acad Dermatol Venereol. 2020 Nov;34(11):e689-e692. doi: 10.1111/jdv.16776. Epub 2020 Jul 28.
4
Pandemic chilblains: Are they SARS-CoV-2-related or not?大流行性寒冷性红斑：与 SARS-CoV-2 相关还是不相关？
Clin Immunol. 2022 Apr;237:108984. doi: 10.1016/j.clim.2022.108984. Epub 2022 Mar 23.
5
COVID-19 pandemic-associated chilblains: more links for SARS-CoV-2 and less evidence for high interferon type I systemic response.与 COVID-19 大流行相关的冻疮：SARS-CoV-2 的更多关联以及 I 型干扰素全身反应增强的证据不足。
Br J Dermatol. 2022 Dec;187(6):1032-1035. doi: 10.1111/bjd.21820. Epub 2022 Sep 1.
6
Response to Reader Comment Regarding "Approach to Chilblains During the COVID-19 Pandemic".对读者关于《COVID-19大流行期间冻疮的处理方法》评论的回复
J Cutan Med Surg. 2021 May-Jun;25(3):344-345. doi: 10.1177/1203475421997405. Epub 2021 Feb 24.
7
Course and outcome of chilblain-like acral lesions during COVID-19 pandemic.2019冠状病毒病大流行期间冻疮样手足部病变的病程及转归
J Eur Acad Dermatol Venereol. 2023 Jan;37(1):e29-e31. doi: 10.1111/jdv.18582. Epub 2022 Oct 1.
8
Evolution of incidence of chilblain-like lesions in children during the first year of COVID-19 pandemic.新冠疫情第一年儿童冻疮样病变发病率的演变
Pediatr Dermatol. 2022 Mar;39(2):243-249. doi: 10.1111/pde.14948. Epub 2022 Feb 7.
9
Long-term Outcome of Chilblains Associated with SARS-CoV-2.冻疮与 SARS-CoV-2 相关的长期结局。
Acta Derm Venereol. 2021 Dec 13;101(12):adv00614. doi: 10.2340/00015555-3930.
10
Lack of association between pandemic chilblains and SARS-CoV-2 infection.大流行性寒冷性红斑与 SARS-CoV-2 感染之间缺乏关联。
Proc Natl Acad Sci U S A. 2022 Mar 1;119(9). doi: 10.1073/pnas.2122090119.
引用本文的文献
1
Enhanced TLR7-dependent production of type I interferon by pDCs underlies pandemic chilblains.浆细胞样树突状细胞（pDCs）中由Toll样受体7（TLR7）依赖性增强的I型干扰素产生是大流行冻疮的基础。
J Exp Med. 2025 Jul 7;222(7). doi: 10.1084/jem.20231467. Epub 2025 Apr 14.
本文引用的文献
1
Biomarkers of Endothelial Damage in Distinct Phases of Multisystem Inflammatory Syndrome in Children.儿童多系统炎症综合征不同阶段内皮损伤的生物标志物
Metabolites. 2022 Jul 24;12(8):680. doi: 10.3390/metabo12080680.
2
Lack of association between pandemic chilblains and SARS-CoV-2 infection.大流行性寒冷性红斑与 SARS-CoV-2 感染之间缺乏关联。
Proc Natl Acad Sci U S A. 2022 Mar 1;119(9). doi: 10.1073/pnas.2122090119.
3
Immunopathological signatures in multisystem inflammatory syndrome in children and pediatric COVID-19.儿童多系统炎症综合征和儿童 COVID-19 的免疫病理特征。
Nat Med. 2022 May;28(5):1050-1062. doi: 10.1038/s41591-022-01724-3. Epub 2022 Feb 17.
4
Type I interferon response and vascular alteration in chilblain-like lesions during the COVID-19 outbreak.COVID-19 疫情期间冻疮样皮损中的 I 型干扰素反应和血管改变。
Br J Dermatol. 2021 Dec;185(6):1176-1185. doi: 10.1111/bjd.20707. Epub 2021 Oct 5.
5
Autoantibodies neutralizing type I IFNs are present in 4% of uninfected individuals over 70 years old and account for 20% of COVID-19 deaths.在 70 岁以上未感染的人群中，有 4%存在中和 I 型干扰素的自身抗体，占 COVID-19 死亡人数的 20%。
Sci Immunol. 2021 Aug 19;6(62). doi: 10.1126/sciimmunol.abl4340.
6
IP-10 and MCP-1 as biomarkers associated with disease severity of COVID-19.IP-10 和 MCP-1 作为与 COVID-19 疾病严重程度相关的生物标志物。
Mol Med. 2020 Oct 29;26(1):97. doi: 10.1186/s10020-020-00230-x.
7
No SARS-CoV-2 antibody response in 25 patients with pseudo-chilblains.25 例假性冻疮患者均未出现 SARS-CoV-2 抗体应答。
Dermatol Ther. 2020 Nov;33(6):e14332. doi: 10.1111/dth.14332. Epub 2020 Oct 5.
8
Autoantibodies against type I IFNs in patients with life-threatening COVID-19.COVID-19 危重症患者体内针对 I 型干扰素的自身抗体。
Science. 2020 Oct 23;370(6515). doi: 10.1126/science.abd4585. Epub 2020 Sep 24.
9
Discordant anti-SARS-CoV-2 spike protein and RNA staining in cutaneous perniotic lesions suggests endothelial deposition of cleaved spike protein.皮肤冻疮样病变中抗SARS-CoV-2刺突蛋白与RNA染色不一致，提示裂解的刺突蛋白在内皮沉积。
J Cutan Pathol. 2021 Jan;48(1):47-52. doi: 10.1111/cup.13866. Epub 2020 Oct 1.
10
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients.严重 COVID-19 患者的 I 型干扰素活性和炎症反应受损。
Science. 2020 Aug 7;369(6504):718-724. doi: 10.1126/science.abc6027. Epub 2020 Jul 13.
Zotero 插件